Top

Published in:

01-09-2021 | Pancreas Transplantation | Letter

Donor insulin use during stay in the intensive care unit should not preclude pancreas transplantation. Reply to Ventura-Aguiar P, Montagud-Marrahi E, Amor AJ et al [letter]

Authors: Iestyn M. Shapey, Angela Summers, Hussein Khambalia, Petros Yiannoullou, Catherine Fullwood, Neil A. Hanley, Titus Augustine, Martin K. Rutter, David van Dellen

Published in: Diabetologia | Issue 9/2021

Excerpt

To the Editor: We welcome the correspondence from Ventura-Aguiar et al [1] regarding our recent publication in Diabetologia [2] and value the opportunity to respond. …

Ventura-Aguiar P, Montagud-Marrahi E, Amor AJ, Diekmann F (2021) Donor insulin use during stay in the intensive care unit should not preclude pancreas transplantation. Diabetologia. https://doi.org/10.1007/s00125-021-05479-3

Shapey IM, Summers A, Khambalia H, Yiannoullou P, Fullwood C, Hanley NA et al (2021) Donor insulin therapy in intensive care predicts early outcomes after pancreas transplantation. Diabetologia 64(6):1375–1384. https://doi.org/10.1007/s00125-021-05411-9CrossRefPubMedPubMedCentral

Masson F, Thicoipe M, Gin H, de Mascarel A, Angibeau RM, Favarel-Garrigues JF et al (1993) The endocrine pancreas in brain-dead donors. A prospective study in 25 patients. Transplantation; 56(2):363–7.

Shapey IM, Summers AM, Augustine T, Rutter MK, van Dellen D (2016) Circulating cell-free unmethylated DNA as a marker of graft dysfunction in pancreas transplantation. Am J Transplant 16(10). https://doi.org/10.1111/ajt.13949

Shapey I, Summers A, O’Sullivan J, Yiannoullou P, Casey J, Forbes S et al (2019) microRNA-375 provides an objective measure of pancreas quality in organ donors. Am J Transplant. 19(S3). Available from: https://atcmeetingabstracts.com/abstract/microrna-375-provides-an-objective-measure-of-pancreas-quality-in-organ-donors/

Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R et al (2018) Defining outcomes for β-cell replacement therapy in the treatment of diabetes. Transplantation 102(9):1479–1486

Shapey IM, Tan ZL, Gioco R, Khambalia H, Fullwood C, Yiannoullou P et al (2021) Peri-transplant glycaemic control as a predictor of pancreas transplant survival. Diabetes Obes Metab 23(1):49–57

Shapey IM, Summers A, Yiannoullou P, Khambalia H, Fullwood C, Hanley NA et al (2020) Donor insulin use predicts beta-cell function after islet transplantation. Diabetes Obes Metab 22(10):1874–1879

Title: Donor insulin use during stay in the intensive care unit should not preclude pancreas transplantation. Reply to Ventura-Aguiar P, Montagud-Marrahi E, Amor AJ et al [letter]
Authors: Iestyn M. Shapey
Angela Summers
Hussein Khambalia
Petros Yiannoullou
Catherine Fullwood
Neil A. Hanley
Titus Augustine
Martin K. Rutter
David van Dellen
Publication date: 01-09-2021
Publisher: Springer Berlin Heidelberg
Keywords: Pancreas Transplantation
Pancreas Transplantation
Insulins
Pancreas Transplantation
Hyperglycemia
Pancreas Transplantation
Insulins
Published in: Diabetologia / Issue 9/2021
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-021-05502-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Donor insulin use during stay in the intensive care unit should not preclude pancreas transplantation. Reply to Ventura-Aguiar P, Montagud-Marrahi E, Amor AJ et al [letter]

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2021

Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors

Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control

AT2R deficiency in mice accelerates podocyte dysfunction in diabetic progeny in a sex-dependent manner

HDL and type 2 diabetes: the chicken or the egg?

Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants

Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT)

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page